<DOC>
	<DOCNO>NCT01023945</DOCNO>
	<brief_summary>The primary purpose study evaluate pharmacodynamic profile ( blood glucose urinary glucose excursion ) ASP1941 patient type 2 diabetes mellitus . Safety , tolerability pharmacokinetics also evaluate .</brief_summary>
	<brief_title>A Study ASP1941 Japanese Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 2 diabetic patient least 12 week HbA1c value 7.0 10.0 % screen Fasting plasma glucose ≥ 126mg/dL &lt; 240mg/dL screen Body Mass Index ( BMI ) 20.0 45.0 kg/m2 . Type 1 diabetes mellitus patient Serum creatinine &gt; upper limit normal Proteinuria（albumin/creatinine ratio &gt; 300mg/g） Dysuria and/or urinary tract infection Significant renal , hepatic cardiovascular disease Severe gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Blood glucose</keyword>
</DOC>